<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="review-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">cYjWRj8MtbdkL7pYRGrcTLb</article-id>
      <article-id pub-id-type="other">00021</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2006001700021</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(06)08700421</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2006001700021</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigo de Revis&#227;o</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A resson&#226;ncia magn&#233;tica como m&#233;todo proped&#234;utico em valvopatia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nigri</surname>
            <given-names>Marcelo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rochitte</surname>
            <given-names>Carlos Eduardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tarasoutchi</surname>
            <given-names>Fl&#225;vio</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grinberg</surname>
            <given-names>Max</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">FM </institution>
        <institution content-type="orgdiv2">Hospital das Cl&#237;nicas</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>10</month>
        <year>2006</year>
      </pub-date>
      <volume>87</volume>
      <issue>4</issue>
      <fpage>534</fpage>
      <lpage>537</lpage>
      <history>
        <date date-type="accepted">
          <day>17</day>
          <month>10</month>
          <year>2005</year>
        </date>
        <date date-type="received">
          <day>12</day>
          <month>08</month>
          <year>2005</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <pub-date publication-format="electronic" date-type="pub">
        <day>21</day>
        <month>11</month>
        <year>2006</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>ARTIGO DE REVIS&#195;O</bold>
    </p>
    <p>
      <bold>A resson&#226;ncia magn&#233;tica como m&#233;todo proped&#234;utico em valvopatia</bold>
    </p>
    <p>
      <bold>Marcelo Nigri; Carlos Eduardo Rochitte; Fl&#225;vio Tarasoutchi; Max Grinberg</bold>
    </p>
    <p>Instituto do Cora&#231;&#227;o do Hospital das Cl&#237;nicas &#150; FMUSP - S&#227;o Paulo, SP</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>A resson&#226;ncia magn&#233;tica (RM) vem se firmando nos &#250;ltimos anos como um dos principais exames complementares n&#227;o-invasivos em cardiologia. Dentre as suas principais vantagens destacam-se a excelente defini&#231;&#227;o anat&#244;mica entre os tecidos, a possibilidade de aquisi&#231;&#227;o e reconstru&#231;&#227;o tridimensionais, a aus&#234;ncia de radia&#231;&#227;o ionizante e o uso de contraste n&#227;o-nefrot&#243;xico (gadol&#237;nio) nas doses clinicamente utilizadas.</p>
    <p>A RM tem sido empregada na avalia&#231;&#227;o de valvopatias quando h&#225; dificuldade t&#233;cnica ecocardiogr&#225;fica (janela ac&#250;stica inadequada, por exemplo) e em casos de diverg&#234;ncia com outros exames, como o cateterismo card&#237;aco. Com o advento das novas t&#233;cnicas de aquisi&#231;&#227;o de imagem, a RM obt&#233;m informa&#231;&#245;es adicionais, relativas &#224; medida precisa das dimens&#245;es das c&#226;maras card&#237;acas, fun&#231;&#227;o e massa ventriculares, volumes de regurgita&#231;&#227;o valvar e caracteriza&#231;&#227;o da fibrose mioc&#225;rdica associada &#224;s valvopatias (<xref ref-type="table" rid="tabela1">tab. 1</xref>).</p>
    <table-wrap id="tabela1">
      <graphic xlink:href="1678-4170-abc-87-04-0534-00021-gt01.jpg"/></table-wrap>
    <p>As principais t&#233;cnicas de RM utilizadas para a avalia&#231;&#227;o das valvas card&#237;acas s&#227;o as seq&#252;&#234;ncias anat&#244;micas est&#225;ticas (<italic>spin-eco</italic> r&#225;pido), a cinerresson&#226;ncia, o mapeamento de fluxo por contraste de fase ou mapa de fluxo e, mais recentemente, a t&#233;cnica de realce tardio mioc&#225;rdico. A cinerresson&#226;ncia &#233; a t&#233;cnica mais utilizada para a avalia&#231;&#227;o das valvas card&#237;acas. Essa seq&#252;&#234;ncia fundamenta-se na aquisi&#231;&#227;o segmentada de imagens din&#226;micas ao longo de alguns ciclos card&#237;acos, permitindo avaliar a movimenta&#231;&#227;o das estruturas em qualquer plano anat&#244;mico. Com a cinerresson&#226;ncia &#233; poss&#237;vel medir, de forma acurada, os di&#226;metros e volumes das c&#226;maras card&#237;acas, assim como a massa e fun&#231;&#227;o ventriculares. A fra&#231;&#227;o de eje&#231;&#227;o ventricular &#233; calculada a partir dos volumes sist&#243;lico e diast&#243;lico de diversos cortes transversais ao eixo principal do cora&#231;&#227;o, cobrindo toda a extens&#227;o ventricular, segundo o m&#233;todo de Simpson<sup>1</sup>. Como vantagem em rela&#231;&#227;o &#224; ecocardiografia bidimensional, n&#227;o s&#227;o feitas suposi&#231;&#245;es geom&#233;tricas do ventr&#237;culo para esse c&#225;lculo. Al&#233;m disso, essa t&#233;cnica n&#227;o &#233; limitada pela conforma&#231;&#227;o tor&#225;cica do paciente, tem baixa variabilidade intra e interobservador e tamb&#233;m permite a an&#225;lise do ventr&#237;culo direito, c&#226;mara usualmente de dif&#237;cil acesso ao ecocardiograma. Por todas essas qualidades, a RM presta-se como um excelente exame para seguimento da fun&#231;&#227;o e massa ventriculares de pacientes valvopatas (com estenose a&#243;rtica, por exemplo), bem como para a compara&#231;&#227;o funcional ap&#243;s alguma interven&#231;&#227;o cir&#250;rgica<sup>2</sup>.</p>
    <p>Essa t&#233;cnica, tamb&#233;m conhecida como codifica&#231;&#227;o de velocidade, &#233; uma extens&#227;o da cinerresson&#226;ncia, e permite determinar a velocidade do fluxo sang&#252;&#237;neo de um vaso ou valva card&#237;aca (<xref ref-type="fig" rid="figura1">fig. 1</xref>). Equivale ao Doppler da ecocardiografia, mas com as vantagens de poder acessar fluxos em qualquer orienta&#231;&#227;o e sem limita&#231;&#227;o de janela ac&#250;stica<sup>3</sup>. Por meio da equa&#231;&#227;o de Bernoulli modificada, tamb&#233;m &#233; poss&#237;vel a determina&#231;&#227;o do gradiente press&#243;rico transvalvar. Essa t&#233;cnica &#233; muito &#250;til para quantificar os dist&#250;rbios valvares (estenose ou insufici&#234;ncia). No entanto, apesar de sua acur&#225;cia, ampla disponibilidade e r&#225;pida aquisi&#231;&#227;o, exige experi&#234;ncia do operador na sele&#231;&#227;o dos par&#226;metros t&#233;cnicos e do plano de corte anat&#244;mico mais apropriados para cada situa&#231;&#227;o cl&#237;nica.</p>
    <fig id="figura1">
      <graphic xlink:href="1678-4170-abc-87-04-0534-00021-gf01.jpg"/></fig>
    <p>Tendo como base a descri&#231;&#227;o detalhada da cin&#233;tica do gadol&#237;nio no mioc&#225;rdio infartado, normal e com obstru&#231;&#227;o microvascular<sup>4</sup> (<xref ref-type="fig" rid="figura2">fig. 2</xref>), foi desenvolvida uma t&#233;cnica de RM que pode destacar de forma clara as diferen&#231;as de concentra&#231;&#227;o de gadol&#237;nio nos diferentes graus de les&#227;o do tecido mioc&#225;rdico. Descrita h&#225; cerca de quatro anos, a t&#233;cnica de realce tardio consiste na aquisi&#231;&#227;o das imagens cerca de dez a vinte minutos ap&#243;s a inje&#231;&#227;o intravenosa de contraste (gadol&#237;nio), precedida de um pulso de invers&#227;o-recupera&#231;&#227;o<sup>5</sup> . Dessa forma &#233; capaz de visibilizar m&#237;nimas &#225;reas de necrose/fibrose no mioc&#225;rdio e apresenta excelente correla&#231;&#227;o com a anatomia patol&#243;gica<sup>6</sup> em diversas cardiopatias<sup>7-9</sup>.</p>
    <fig id="figura2">
      <graphic xlink:href="1678-4170-abc-87-04-0534-00021-gf02.jpg"/></fig>
    <p>Recentemente, utilizamos o realce tardio em pacientes com valvopatia a&#243;rtica (estenose ou insufici&#234;ncia) acentuada e art&#233;rias coron&#225;rias normais (<xref ref-type="fig" rid="figura3">fig. 3</xref>). Os pacientes foram avaliados pela RM antes e depois da cirurgia valvar, sendo observadas &#225;reas de fibrose mioc&#225;rdica em 60% dos casos. A presen&#231;a de fibrose mioc&#225;rdica &#224; RM teve correla&#231;&#227;o com o grau de disfun&#231;&#227;o ventricular esquerda e boa acur&#225;cia comparada &#224; bi&#243;psia mioc&#225;rdica realizada durante a cirurgia<sup>10-14</sup>.</p>
    <fig id="figura3">
      <graphic xlink:href="1678-4170-abc-87-04-0534-00021-gf03.jpg"/></fig>
    <p>Para avaliar estenose valvar, utiliza-se um plano de corte perpendicular ao plano valvar que possibilita a observa&#231;&#227;o de valvas espessadas, fusionadas e/ou de menor mobilidade. A cinerresson&#226;ncia permite a visibiliza&#231;&#227;o do jato de turbul&#234;ncia sist&#243;lica gerado pela estenose valvar e a mensura&#231;&#227;o das dimens&#245;es, espessura e fun&#231;&#227;o das c&#226;maras card&#237;acas. Na estenose a&#243;rtica pode ser observados hipertrofia ventricular pela sobrecarga de press&#227;o, dilata&#231;&#227;o arterial p&#243;s-esten&#243;tica e jato de turbul&#234;ncia sist&#243;lica na via de sa&#237;da ventricular. J&#225; na estenose das valvas atrioventriculares os principais achados s&#227;o o aumento atrial e o jato de turbul&#234;ncia diast&#243;lica na via de entrada ventricular. Existem v&#225;rias maneiras de se quantificar a estenose valvar pela RM. A magnitude do jato de turbul&#234;ncia sist&#243;lica observado &#224; cinerresson&#226;ncia pode fornecer uma id&#233;ia da intensidade da estenose (m&#233;todo semiquantitativo), mas n&#227;o deve ser considerado isoladamente como par&#226;metro de gravidade do dist&#250;rbio valvar. Tamb&#233;m com a cinerresson&#226;ncia &#233; poss&#237;vel determinar a <italic>&#225;rea valvar</italic> por planimetria direta. A presen&#231;a de calcifica&#231;&#227;o, que gera perda de sinal &#224; RM, pode causar superestima&#231;&#227;o da &#225;rea de abertura valvar pela planimetria, mas em geral esse m&#233;todo apresenta excelente correla&#231;&#227;o com a ecocardiografia<sup>15</sup>. As medidas de velocidade de fluxo, &#225;rea valvar e gradiente press&#243;rico transvalvar pela RM com a t&#233;cnica de contraste de fase demonstram estreita correla&#231;&#227;o com o Doppler e o cateterismo em pacientes com estenose mitral e a&#243;rtica<sup>16,17</sup>.</p>
    <p>Um dos pontos fortes da RM na avalia&#231;&#227;o das valvopatias &#233; a sua habilidade de mensurar de forma precisa <italic>o</italic> volume e a fra&#231;&#227;o regurgitantes, na insufici&#234;ncia valvar. Para esse fim, a RM foi considerada m&#233;todo de imagem de primeira linha no consenso de RM cardiovascular da Sociedade de Resson&#226;ncia Magn&#233;tica Cardiovascular e da Sociedade Europ&#233;ia de Cardiologia, recentemente publicado<sup>18</sup>.</p>
    <p>Uma das principais preocupa&#231;&#245;es do cardiologista &#233; a seguran&#231;a da RM em portadores de pr&#243;tese valvar mec&#226;nica. Atualmente j&#225; est&#225; bem estabelecido que &#233; seguro expor um portador desse tipo de pr&#243;tese aos campos magn&#233;ticos habitualmente utilizados em RM (1,5 Tesla)<sup>19</sup>. A for&#231;a magn&#233;tica sobre o material &#233; muito pequena diante daquela exercida pela fixa&#231;&#227;o cir&#250;rgica da pr&#243;tese. Essas pr&#243;teses, por sua vez, produzem um artefato de perda de sinal (&#225;rea escura na imagem) em fun&#231;&#227;o da distor&#231;&#227;o do campo magn&#233;tico pelo conte&#250;do met&#225;lico. Em geral esse artefato se estende para as estruturas adjacentes, o que varia conforme a seq&#252;&#234;ncia de pulso utilizada (usualmente menor extens&#227;o nas seq&#252;&#234;ncias de <italic>spin-eco</italic>). Conseq&#252;entemente, a avalia&#231;&#227;o de jatos de turbul&#234;ncia de fluxo valvar, principalmente os de pequena magnitude, fica prejudicada. Com as pr&#243;teses biol&#243;gicas, em geral esse efeito fica restrito ao anel valvar e n&#227;o chega a interferir de forma significativa na interpreta&#231;&#227;o do exame.</p>
    <p>Como todo exame, entretanto, a RM tem limita&#231;&#245;es, que devem ser levadas em considera&#231;&#227;o ao indic&#225;-la. Todas as seq&#252;&#234;ncias de pulso card&#237;acas s&#227;o obtidas com sincroniza&#231;&#227;o eletrocardiogr&#225;fica. Em pacientes portadores de arritmias, algo comum entre valvopatas, essa sincroniza&#231;&#227;o &#233; prejudicada, o que pode comprometer a qualidade do exame. Al&#233;m disso, a aquisi&#231;&#227;o das imagens quase sempre &#233; realizada em apn&#233;ia de alguns segundos. Pacientes dispn&#233;icos ou com insufici&#234;ncia card&#237;aca descompensada n&#227;o costumam toler&#225;-la, o que tamb&#233;m reduz a qualidade das imagens. Cerca de 2% dos pacientes n&#227;o conseguem suportar o exame por claustrofobia. J&#225; os implantes met&#225;licos cerebrais constituem contra-indica&#231;&#227;o formal &#224; RM, a n&#227;o ser que comprovadamente n&#227;o apresentem propriedades ferromagn&#233;ticas. Finalmente, a presen&#231;a de marcapasso ou cardioversor-desfibrilador implant&#225;vel tamb&#233;m &#233; considerada contra-indica&#231;&#227;o ao exame, embora alguns estudos tenham demonstrado sua seguran&#231;a nos aparelhos de 1,5 Tesla<sup>20</sup>.</p>
    <p>A RM configura-se, portanto, como um m&#233;todo seguro incorporado ao arsenal proped&#234;utico das valvopatias.</p>
    <p>
      <graphic xlink:href="1678-4170-abc-87-04-0534-00021-e01.jpg"/></p>
    <p>
      <fn id="back" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Marcelo Nigri </p>
        <p> Dr. En&#233;as de Carvalho Aguiar, 44 </p>
        <p> 05403-000 &#150; S&#227;o Paulo, SP </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="marcelonigri@uol.com.br">marcelonigri@uol.com.br</email>
        </p>
      </fn>
    </p>
    <p>Recebido em 12/08/05 </p>
    <p> Aceito em 17/10/05</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Rehr RB, Malloy    CR, Filipchuk NG, et al. Left ventricular volumes measured by MR imaging. Radiology.    1985; 156: 717-19.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Left ventricular volumes measured by MR imaging</article-title>
          <source>Radiology.</source>
          <date>
            <year>1985</year>
          </date>
          <fpage>717</fpage>
          <lpage>19</lpage>
          <volume>156</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rehr</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Malloy</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Filipchuk</surname>
              <given-names>NG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Mohiaddin RH, Kilner PJ. Valvular Heart Disease. In: Manning WJ, Pennell DJ, editors. Cardiovascular Magnetic Resonance. Philadelphia, PA: Churchill Livingstone; 2002: 387-404.</mixed-citation>
        <element-citation publication-type="book">
          <source>Cardiovascular Magnetic Resonance</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>387</fpage>
          <lpage>404</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Mohiaddin</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Kilner</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Manning</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Pennell</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Mohiaddin RH, Longmore DB. Functional aspects of cardiovascular nuclear magnetic resonance imaging. Techniques and application. Circulation. 1993; 88: 264-81.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Functional aspects of cardiovascular nuclear magnetic resonance imaging: Techniques and application</article-title>
          <source>Circulation.</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>264</fpage>
          <lpage>81</lpage>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mohiaddin</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Longmore</surname>
              <given-names>DB.</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Rochitte CE, Lima JA, Bluemke DA, et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation. 1998; 98: 1006-14.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction</article-title>
          <source>Circulation.</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>1006</fpage>
          <lpage>14</lpage>
          <volume>98</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rochitte</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Bluemke</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001; 218: 215-23.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>An improved MR imaging technique for the visualization of myocardial infarction</article-title>
          <source>Radiology.</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>215</fpage>
          <lpage>23</lpage>
          <volume>218</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Simonetti</surname>
              <given-names>OP</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Fieno</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003; 361: 374-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study</article-title>
          <source>Lancet.</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>374</fpage>
          <lpage>9</lpage>
          <volume>361</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wagner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mahrholdt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Holly</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Wilson JM, Villareal RP, Hariharan R, et al. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Tex Heart Inst J. 2002; 29: 176-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy</article-title>
          <source>Tex Heart Inst J.</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>176</fpage>
          <lpage>80</lpage>
          <volume>29</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wilson</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Villareal</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Hariharan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004; 109: 1250-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology</article-title>
          <source>Circulation.</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1250</fpage>
          <lpage>8</lpage>
          <volume>109</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mahrholdt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Goedecke</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Serra JJ, Monte GU, Mello ES, et al. Images in cardiovascular medicine. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging. Circulation. 2003; 107: 188-e189.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Images in cardiovascular medicine: Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging</article-title>
          <source>Circulation.</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>188</fpage>
          <lpage>e189</lpage>
          <volume>107</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Serra</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Monte</surname>
              <given-names>GU</given-names>
            </name>
            <name>
              <surname>Mello</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Nigri M. Fibrose mioc&#225;rdica em valvopatia a&#243;rtica: estudo comparativo entre a resson&#226;ncia magn&#233;tica e bi&#243;psia intra-operat&#243;ria mioc&#225;rdica. S&#227;o Paulo, 2004. Tese (Doutorado) - Departamento de Cardiopneumologia, Faculdade de Medicina da Universidade de S&#227;o Paulo.</mixed-citation>
        <element-citation publication-type="thesis">
          <source>Fibrose mioc&#225;rdica em valvopatia a&#243;rtica: estudo comparativo entre a resson&#226;ncia magn&#233;tica e bi&#243;psia intra-operat&#243;ria mioc&#225;rdica</source>
          <date>
            <year>2004</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Nigri</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Nigri M, Rochitte C, Tarasoutchi F, et al. Myocardial fibrosis detected by MRI and biopsy is associated with worse left ventricular function in patients with severe chronic aortic valve disease. Circulation. 2003; 108 [17 (S-IV)]: 567 (abstract).</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myocardial fibrosis detected by MRI and biopsy is associated with worse left ventricular function in patients with severe chronic aortic valve disease</article-title>
          <source>Circulation</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>567</fpage>
          <issue>17</issue>
          <volume>108</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nigri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rochitte</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tarasoutchi</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Nigri M, Rochitte C, Tarasoutchi F, et al. Delayed-enhanced magnetic resonance imaging detects myocardial fibrosis in patients with chronic aortic valve disease. J Am Coll Cardiol. 2004; 41 [6 (SA)]: 450 (abstract).</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Delayed-enhanced magnetic resonance imaging detects myocardial fibrosis in patients with chronic aortic valve disease</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>450</fpage>
          <issue>6</issue>
          <volume>41</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nigri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rochitte</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tarasoutchi</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Nigri M, Grimberg M, Tarasoutchi F, et al. Myocardial delayed enhancement MRI detects myocardial fibrosis and is associated with worse left ventricular function and biopsy increased collagen content in patients with severe chronic aortic valve disease. J Cardiovasc Magn Reson. 2004; 6: 86 (abstract).</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myocardial delayed enhancement MRI detects myocardial fibrosis and is associated with worse left ventricular function and biopsy increased collagen content in patients with severe chronic aortic valve disease</article-title>
          <source>J Cardiovasc Magn Reson</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>86</fpage>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nigri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grimberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tarasoutchi</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Nigri M, Rochitte C, Tarasoutchi F, et al. Relationship of myocardial fibrosis by delayed enhancement MRI with biopsy-quantified collagen content in patients with severe chronic aortic valve disease. Circulation. 2004; 110: 572 (abstract).</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relationship of myocardial fibrosis by delayed enhancement MRI with biopsy-quantified collagen content in patients with severe chronic aortic valve disease</article-title>
          <source>Circulation</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>572</fpage>
          <volume>110</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nigri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rochitte</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tarasoutchi</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. John AS, Dill T, Brandt RR, et al. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? J Am Coll Cardiol. 2003; 42: 519-26.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards?</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>519</fpage>
          <lpage>26</lpage>
          <volume>42</volume>
          <person-group person-group-type="author">
            <name>
              <surname>John</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Dill</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Kilner PJ, Manzara CC, Mohiaddin RH, et al. Magnetic resonance jet velocity mapping in mitral and aortic valve stenosis. Circulation. 1993; 87: 1239-48.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Magnetic resonance jet velocity mapping in mitral and aortic valve stenosis</article-title>
          <source>Circulation.</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>1239</fpage>
          <lpage>48</lpage>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kilner</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Manzara</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Mohiaddin</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Caruthers SD, Lin SJ, Brown P, et al. Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography. Circulation. 2003; 108: 2236-43.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography</article-title>
          <source>Circulation.</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>2236</fpage>
          <lpage>43</lpage>
          <volume>108</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Caruthers</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004; 25: 1940-65.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report</article-title>
          <source>Eur Heart J.</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1940</fpage>
          <lpage>65</lpage>
          <volume>25</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pennell</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Sechtem</surname>
              <given-names>UP</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>CB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Edwards MB, Taylor KM, Shellock FG. Prosthetic heart valves: evaluation of magnetic field interactions, heating, and artifacts at 1.5 T. J Magn Reson Imaging. 2000; 12: 363-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prosthetic heart valves: evaluation of magnetic field interactions, heating, and artifacts at 1. 5 T</article-title>
          <source>J Magn Reson Imaging</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>363</fpage>
          <lpage>9</lpage>
          <volume>12</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Edwards</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Shellock</surname>
              <given-names>FG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Martin ET,    Coman JA, Shellock FG, et al. Magnetic resonance imaging and cardiac pacemaker    safety at 1.5-Tesla. J Am Coll Cardiol. 2004; 43: 1315-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Magnetic resonance imaging and cardiac pacemaker safety at 1. 5-Tesla</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1315</fpage>
          <lpage>24</lpage>
          <volume>43</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Coman</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Shellock</surname>
              <given-names>FG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Magnetic resonance imaging is image diagnosis in heart valve disease</article-title>
      </title-group>
    </front-stub>
    <body>
      <p>
        <bold>REVIEW ARTICLE</bold>
      </p>
      <p>
        <bold>Magnetic resonance imaging as image diagnosis in heart valve disease</bold>
      </p>
      <p>
        <bold>Marcelo Nigri; Carlos Eduardo Rochitte; Fl&#225;vio Tarasoutchi; Max Grinberg</bold>
      </p>
      <p>Instituto do Cora&#231;&#227;o do Hospital das Cl&#237;nicas - FMUSP - S&#227;o Paulo, SP, Brazil</p>
      <p>
        <xref ref-type="corresp" rid="back-body2">Mailing Address</xref>
      </p>
      <p>In most recent years, magnetic resonance imaging (MRI) has been establishing itself as one of the major non-invasive complementary exams in Cardiology. Among the major benefits to be pointed out are the excellent anatomic definition between tissues, the possibility of three-dimensional acquisition and reconstruction, the absence of ionizing radiation, and the use of non-nephrotoxic contrast (gadolinium) in the doses clinically used.</p>
      <p>MRI has been used to assess valve disease whenever echocardiographic technique is hard to be used (improper acoustic window, for instance) and whenever there are conflicts with other exams, as heart catheterism. With the rise of new image acquisition techniques, MRI collects additional information related to accurate measure of heart chamber dimensions, ventricular function and mass, valvular regurgitation volumes and characterization of myocardial fibrosis associated to valve diseases (<xref ref-type="table" rid="tabela1-body2">Tab. 1</xref>).</p>
      <table-wrap id="tabela1-body2">
        <graphic xlink:href="1678-4170-abc-87-04-0534-00021-gt01-en.jpg"/></table-wrap>
      <p>MRI major techniques to assess heart valves are static anatomy sequences (fast spin-echo), cine magnetic resonance, flow mapping through phase contrast or flow map, and more recently, myocardial delayed enhancement MRI. Cine magnetic resonance is the most commonly used technique for the assessment of heart valves. The sequence is based on the segmented acquisition of dynamic images along some heart cycles, therefore allowing the assessment of structures movement in any anatomic plane. Cine magnetic resonance allows accurate measuring of cardiac chambers diameters and volumes, as well as ventricular mass and function. Ventricular ejection fraction is calculated based on systolic and diastolic volumes of different views transversally to heart main axis, thus covering all ventricular extension, following <italic>Simpson</italic>'s<sup>1</sup> method. As compared to bidimensional echocardiography, one advantage is that no ventricular geometric assumptions are made for this calculation. Additionally, the technique is not limited by patient's thoracic format; it presents low intra and interobserver's variability, and also allows right ventricle analysis, a chamber usually hard to access through echocardiogram. All those qualities make MRI an excellent exam for the follow-up of valve disease patients' ventricular function and mass (with aortic stenosis, for instance) as well as for functional comparison after a surgical intervention<sup>2</sup>.</p>
      <p>The technique &#150; also known as velocity coding &#150; is an extension to the cine magnetic resonance, and allows the determination of blood flow velocity from a vase or a cardiac valve (<xref ref-type="fig" rid="figura1-body2">Fig. 1</xref>). It is an equivalent to <italic>Doppler</italic> in echocardiography, but it has the advantage of allowing flow access in any direction with no acoustic window limitation<sup>3</sup>. Through the Bernoulli modified equation, it is also possible to determine transvalvular pressure gradient. This technique is very useful to quantify valvular disorders (stenosis or failure). However, despite technique accuracy, wide availability, and fast acquisition, it demands experience on the part of the operator in selecting most appropriate technical parameters and anatomic view scan for each clinical scenario.</p>
      <fig id="figura1-body2">
        <graphic xlink:href="1678-4170-abc-87-04-0534-00021-gf01-en.jpg"/></fig>
      <p>Based on a detailed description of gadolinium kinetics in the myocardium that is infarcted, normal or with microvascular obstruction<sup>4</sup> (<xref ref-type="fig" rid="figura2-body2">Fig. 2</xref>) an MRI technique was developed to clearly point out gadolinium concentration of myocardial tissue different injury levels. Described approximately 4 years ago, the delayed enhancement technique consists in the acquisition of images about 10 to 20 minutes after intravenous contrast injection (gadolinium), preceded by an inversion-recovery pulse<sup>5</sup>.</p>
      <fig id="figura2-body2">
        <graphic xlink:href="1678-4170-abc-87-04-0534-00021-gf02-en.jpg"/></fig>
      <p>Thus, it allows the visualization of minimal myocardial necrosis/fibrosis areas, and provides excellent correlation with pathologic anatomy<sup>6</sup> in different cardiopathies<sup>7-9</sup>.</p>
      <p>The delayed enhancement technique has recently been used in patients with marked aortic valve disease (stenosis or failure) and normal coronary arteries (<xref ref-type="fig" rid="figura3-body2">Fig. 3</xref>). Patients have been assessed through MRI before and after valvular surgery, with myocardial fibrosis having been observed in 60% of cases. The presence of myocardial fibrosis at MRI had correlation with the level of left ventricular dysfunction and good accuracy when compared to the myocardial biopsy carried out during the surgery<sup>10-14</sup>.</p>
      <fig id="figura3-body2">
        <graphic xlink:href="1678-4170-abc-87-04-0534-00021-gf03-en.jpg"/></fig>
      <p>For valvular assessment a view plane perpendicular to valvular plane is used to allow for the observation of thickened, fusioned and/or lower mobility valves. Cine magnetic resonance allows the visualization of the systolic turbulence squirt generated by valvular stenosis and the measuring of cardiac chambers dimensions, thickness, and function. In aortic stenosis ventricular hypertrophy due to pressure overload, post-stenotic arterial dilation, and systolic turbulence squirt in ventricular exit can be observed. In atrioventricular valves stenosis, in its turn, major findings are atrial enlargement and diastolic turbulence squirt in ventricular entry site. There are different ways to quantify valvular stenosis using MRI. Systolic turbulence squirt observed through cine magnetic resonance may provide a clue of stenosis intensity (semi-quantitative method), but it should not be considered as an isolated parameter for valvular disorder severity. Cine magnetic resonance also helps determine <italic>valvular area</italic> through direct planimetry. Calcification &#150; which generates MRI signal loss &#150; may result in overestimating valvular opening area through planimetry, although generally speaking the method provides excellent correlation with echocardiography<sup>15</sup>. Flow velocity, valvular area, and transvalvular pressure gradient measures through MRI with phase contrast technique show close correlation with <italic>Doppler</italic> and catheterism in patients with mitral and aortic stenosis<sup>16,17</sup>.</p>
      <p>One of MRI strengths in valve disease assessment is its ability in accurately measuring regurgitation volume and fraction in valvular failure. For such purpose, MRI has been considered first line imaging method in the recently published cardiovascular MRI consensus of the Magnetic Resonance Imaging Society and of the European Society of Cardiology<sup>18</sup>.</p>
      <p>One of cardiologists' major concern is the safety of MRI in patients with mechanic valvular prosthesis. Today, it has been made clear that it is safe to expose those using that kind of prosthesis to the magnetic fields used for MRI (1.5 Tesla)<sup>19</sup>. Magnetic power over the material is very small if compared to that of prosthesis surgical fixation. On the other hand, those prostheses result in a signal loss artifact (dark area in image) due to magnetic field distortion from its metallic content. That artifact usually extends to adjacent structures, which varies according to the pulse sequence used (usually smaller extension in spin-echo sequence). Consequently, the assessment of valvular flow turbulence squirts &#150; especially those of low magnitude &#150; is jeopardized. With biological prostheses, that effect is usually restricted to the valvular ring and does not significantly interfere in exam interpretation.</p>
      <p>However, as in every exam, MRI faces limitations that must be taken into account when indicated. All cardiac pulse sequences are obtained through electrocardiographic synchronization. In patients with arrhythmia &#150; a common condition among valve disease patients &#150; that synchronization is jeopardized, which may compromise exam quality standard. Additionally, image acquisition is almost always carried out in some seconds' apnea. Dyspneic or decompensated heart failure patients are usually not tolerant, which also reduces image quality. Approximately 2% of patients cannot tolerate the exam due to claustrophobia. Brain metallic implantations are a formal contra-indication to MRI, unless there is proof of no ferromagnetic properties. Finally, a pacemaker or an implantable cardioversor-defibrillator is also considered contra-indication to the exam, although some studies have shown it to be safe in 1.5 Tesla equipment<sup>20</sup>.</p>
      <p>Therefore, MRI has shown to be a safe method to be incorporated to the propedeutic arsenal for valve diseases. </p>
      <p>
        <graphic xlink:href="1678-4170-abc-87-04-0534-00021-e01-en.jpg"/></p>
      <p>
        <bold>References</bold>
      </p>
      <p>
        <fn id="back-body2" fn-type="corresp">
          <label>
            <bold>Mailing address:</bold>
          </label>
          <p> Marcelo Nigri</p>
          <p> Dr. En&#233;as de Carvalho Aguiar, 44</p>
          <p> O5403-000 &#150; S&#227;o Paulo, SP &#150; Brazil</p>
          <p> E-mail: </p>
          <p>
            <email xlink:href="marcelonigri@uol.com.br">marcelonigri@uol.com.br</email>
          </p>
        </fn>
      </p>
      <p>Received on 08/12/05</p>
      <p> Accepted on 10/17/05</p>
    </body>
  </sub-article>
</article>
